List of Tables
Table 1. Global AAV-based Gene Therapy Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AAV-based Gene Therapy Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AAV-based Gene Therapy Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AAV-based Gene Therapy Products Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AAV-based Gene Therapy Products Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global AAV-based Gene Therapy Products Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global AAV-based Gene Therapy Products Sales by Region (2020-2025) & (Units)
Table 8. Global AAV-based Gene Therapy Products Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global AAV-based Gene Therapy Products Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global AAV-based Gene Therapy Products Sales Share by Manufacturers (2020-2025)
Table 12. Global AAV-based Gene Therapy Products Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global AAV-based Gene Therapy Products Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global AAV-based Gene Therapy Products by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV-based Gene Therapy Products as of 2024)
Table 16. Global AAV-based Gene Therapy Products Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global AAV-based Gene Therapy Products Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers AAV-based Gene Therapy Products Manufacturing Base and Headquarters
Table 19. Global AAV-based Gene Therapy Products Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global AAV-based Gene Therapy Products Sales by Type (2020-2025) & (Units)
Table 23. Global AAV-based Gene Therapy Products Sales by Type (2026-2031) & (Units)
Table 24. Global AAV-based Gene Therapy Products Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global AAV-based Gene Therapy Products Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global AAV-based Gene Therapy Products ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global AAV-based Gene Therapy Products Sales by Application (2020-2025) & (Units)
Table 29. Global AAV-based Gene Therapy Products Sales by Application (2026-2031) & (Units)
Table 30. AAV-based Gene Therapy Products High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global AAV-based Gene Therapy Products Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global AAV-based Gene Therapy Products Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global AAV-based Gene Therapy Products ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America AAV-based Gene Therapy Products Growth Accelerators and Market Barriers
Table 37. North America AAV-based Gene Therapy Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America AAV-based Gene Therapy Products Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe AAV-based Gene Therapy Products Growth Accelerators and Market Barriers
Table 40. Europe AAV-based Gene Therapy Products Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe AAV-based Gene Therapy Products Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific AAV-based Gene Therapy Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific AAV-based Gene Therapy Products Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific AAV-based Gene Therapy Products Growth Accelerators and Market Barriers
Table 45. Southeast Asia AAV-based Gene Therapy Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America AAV-based Gene Therapy Products Investment Opportunities and Key Challenges
Table 47. Central and South America AAV-based Gene Therapy Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa AAV-based Gene Therapy Products Investment Opportunities and Key Challenges
Table 49. Middle East and Africa AAV-based Gene Therapy Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. uniQure Corporation Information
Table 51. uniQure Description and Major Businesses
Table 52. uniQure Product Models, Descriptions and Specifications
Table 53. uniQure Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. uniQure Sales Value Proportion by Product in 2024
Table 55. uniQure Sales Value Proportion by Application in 2024
Table 56. uniQure Sales Value Proportion by Geographic Area in 2024
Table 57. uniQure AAV-based Gene Therapy Products SWOT Analysis
Table 58. uniQure Recent Developments
Table 59. Spark Therapeutics Corporation Information
Table 60. Spark Therapeutics Description and Major Businesses
Table 61. Spark Therapeutics Product Models, Descriptions and Specifications
Table 62. Spark Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Spark Therapeutics Sales Value Proportion by Product in 2024
Table 64. Spark Therapeutics Sales Value Proportion by Application in 2024
Table 65. Spark Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 66. Spark Therapeutics AAV-based Gene Therapy Products SWOT Analysis
Table 67. Spark Therapeutics Recent Developments
Table 68. AveXis (Novartis) Corporation Information
Table 69. AveXis (Novartis) Description and Major Businesses
Table 70. AveXis (Novartis) Product Models, Descriptions and Specifications
Table 71. AveXis (Novartis) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. AveXis (Novartis) Sales Value Proportion by Product in 2024
Table 73. AveXis (Novartis) Sales Value Proportion by Application in 2024
Table 74. AveXis (Novartis) Sales Value Proportion by Geographic Area in 2024
Table 75. AveXis (Novartis) AAV-based Gene Therapy Products SWOT Analysis
Table 76. AveXis (Novartis) Recent Developments
Table 77. PTC Therapeutics Corporation Information
Table 78. PTC Therapeutics Description and Major Businesses
Table 79. PTC Therapeutics Product Models, Descriptions and Specifications
Table 80. PTC Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. PTC Therapeutics Sales Value Proportion by Product in 2024
Table 82. PTC Therapeutics Sales Value Proportion by Application in 2024
Table 83. PTC Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 84. PTC Therapeutics AAV-based Gene Therapy Products SWOT Analysis
Table 85. PTC Therapeutics Recent Developments
Table 86. BioMarin Corporation Information
Table 87. BioMarin Description and Major Businesses
Table 88. BioMarin Product Models, Descriptions and Specifications
Table 89. BioMarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BioMarin Sales Value Proportion by Product in 2024
Table 91. BioMarin Sales Value Proportion by Application in 2024
Table 92. BioMarin Sales Value Proportion by Geographic Area in 2024
Table 93. BioMarin AAV-based Gene Therapy Products SWOT Analysis
Table 94. BioMarin Recent Developments
Table 95. Sarepta Therapeutics Corporation Information
Table 96. Sarepta Therapeutics Description and Major Businesses
Table 97. Sarepta Therapeutics Product Models, Descriptions and Specifications
Table 98. Sarepta Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Sarepta Therapeutics Recent Developments
Table 100. Roche Corporation Information
Table 101. Roche Description and Major Businesses
Table 102. Roche Product Models, Descriptions and Specifications
Table 103. Roche Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Roche Recent Developments
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Product Models, Descriptions and Specifications
Table 108. Pfizer Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Pfizer Recent Developments
Table 110. CSL Behring Corporation Information
Table 111. CSL Behring Description and Major Businesses
Table 112. CSL Behring Product Models, Descriptions and Specifications
Table 113. CSL Behring Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. CSL Behring Recent Developments
Table 115. Sangamo Therapeutics Corporation Information
Table 116. Sangamo Therapeutics Description and Major Businesses
Table 117. Sangamo Therapeutics Product Models, Descriptions and Specifications
Table 118. Sangamo Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Sangamo Therapeutics Recent Developments
Table 120. Biogen Corporation Information
Table 121. Biogen Description and Major Businesses
Table 122. Biogen Product Models, Descriptions and Specifications
Table 123. Biogen Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Biogen Recent Developments
Table 125. Freeline Therapeutics Corporation Information
Table 126. Freeline Therapeutics Description and Major Businesses
Table 127. Freeline Therapeutics Product Models, Descriptions and Specifications
Table 128. Freeline Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Freeline Therapeutics Recent Developments
Table 130. Coave Therapeutics Corporation Information
Table 131. Coave Therapeutics Description and Major Businesses
Table 132. Coave Therapeutics Product Models, Descriptions and Specifications
Table 133. Coave Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Coave Therapeutics Recent Developments
Table 135. MeiraGTx Corporation Information
Table 136. MeiraGTx Description and Major Businesses
Table 137. MeiraGTx Product Models, Descriptions and Specifications
Table 138. MeiraGTx Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. MeiraGTx Recent Developments
Table 140. RegenxBio Corporation Information
Table 141. RegenxBio Description and Major Businesses
Table 142. RegenxBio Product Models, Descriptions and Specifications
Table 143. RegenxBio Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. RegenxBio Recent Developments
Table 145. Asklepios Biopharmaceutical Corporation Information
Table 146. Asklepios Biopharmaceutical Description and Major Businesses
Table 147. Asklepios Biopharmaceutical Product Models, Descriptions and Specifications
Table 148. Asklepios Biopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Asklepios Biopharmaceutical Recent Developments
Table 150. Audentes Therapeutics Corporation Information
Table 151. Audentes Therapeutics Description and Major Businesses
Table 152. Audentes Therapeutics Product Models, Descriptions and Specifications
Table 153. Audentes Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Audentes Therapeutics Recent Developments
Table 155. Neurophth Corporation Information
Table 156. Neurophth Description and Major Businesses
Table 157. Neurophth Product Models, Descriptions and Specifications
Table 158. Neurophth Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Neurophth Recent Developments
Table 160. Belief BioMed Corporation Information
Table 161. Belief BioMed Description and Major Businesses
Table 162. Belief BioMed Product Models, Descriptions and Specifications
Table 163. Belief BioMed Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Belief BioMed Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. AAV-based Gene Therapy Products Product Picture
Figure 2. Global AAV-based Gene Therapy Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. AAV2 Product Picture
Figure 4. AAV8 Product Picture
Figure 5. AAV9 Product Picture
Figure 6. Others Product Picture
Figure 7. Global AAV-based Gene Therapy Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Haematology
Figure 9. Ophthalmology
Figure 10. Neurology
Figure 11. Musculoskeletal
Figure 12. Others
Figure 13. AAV-based Gene Therapy Products Report Years Considered
Figure 14. Global AAV-based Gene Therapy Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 16. Global AAV-based Gene Therapy Products Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global AAV-based Gene Therapy Products Revenue Market Share by Region (2020-2031)
Figure 18. Global AAV-based Gene Therapy Products Sales (2020-2031) & (Units)
Figure 19. Global AAV-based Gene Therapy Products Sales (CAGR) by Region (2020-2031) (Units)
Figure 20. Global AAV-based Gene Therapy Products Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers AAV-based Gene Therapy Products Sales Volume Market Share in 2024
Figure 22. Global AAV-based Gene Therapy Products Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. AAV2 Revenue Market Share by Manufacturer in 2024
Figure 25. AAV8 Revenue Market Share by Manufacturer in 2024
Figure 26. AAV9 Revenue Market Share by Manufacturer in 2024
Figure 27. Others Revenue Market Share by Manufacturer in 2024
Figure 28. Global AAV-based Gene Therapy Products Sales Market Share by Type (2020-2031)
Figure 29. Global AAV-based Gene Therapy Products Revenue Market Share by Type (2020-2031)
Figure 30. Global AAV-based Gene Therapy Products Sales Market Share by Application (2020-2031)
Figure 31. Global AAV-based Gene Therapy Products Revenue Market Share by Application (2020-2031)
Figure 32. North America AAV-based Gene Therapy Products Sales YoY (2020-2031) & (Units)
Figure 33. North America AAV-based Gene Therapy Products Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Manufacturers AAV-based Gene Therapy Products Sales Revenue (US$ Million) in 2024
Figure 35. North America AAV-based Gene Therapy Products Sales Volume (Units) by Type (2020- 2031)
Figure 36. North America AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 37. North America AAV-based Gene Therapy Products Sales Volume (Units) by Application (2020-2031)
Figure 38. North America AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 39. US AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 40. Canada AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 41. Mexico AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 42. Europe AAV-based Gene Therapy Products Sales YoY (2020-2031) & (Units)
Figure 43. Europe AAV-based Gene Therapy Products Revenue YoY (2020-2031) & (US$ Million)
Figure 44. Europe Top 5 Manufacturers AAV-based Gene Therapy Products Sales Revenue (US$ Million) in 2024
Figure 45. Europe AAV-based Gene Therapy Products Sales Volume (Units) by Type (2020-2031)
Figure 46. Europe AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Type (2020-2031)
Figure 47. Europe AAV-based Gene Therapy Products Sales Volume (Units) by Application (2020-2031)
Figure 48. Europe AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. Germany AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 50. France AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 51. U.K. AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 52. Italy AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 53. Russia AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific AAV-based Gene Therapy Products Sales YoY (2020-2031) & (Units)
Figure 55. Asia-Pacific AAV-based Gene Therapy Products Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific Top 8 Manufacturers AAV-based Gene Therapy Products Sales Revenue (US$ Million) in 2024
Figure 57. Asia-Pacific AAV-based Gene Therapy Products Sales Volume (Units) by Type (2020- 2031)
Figure 58. Asia-Pacific AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 59. Asia-Pacific AAV-based Gene Therapy Products Sales Volume (Units) by Application (2020-2031)
Figure 60. Asia-Pacific AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 61. Indonesia AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 62. Japan AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 63. South Korea AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 64. China Taiwan AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 65. India AAV-based Gene Therapy Products Revenue (2020-2031) & (US$ Million)
Figure 66. Central and South America AAV-based Gene Therapy Products Sales YoY (2020-2031) & (Units)
Figure 67. Central and South America AAV-based Gene Therapy Products Revenue YoY (2020-2031) & (US$ Million)
Figure 68. Central and South America Top 5 Manufacturers AAV-based Gene Therapy Products Sales Revenue (US$ Million) in 2024
Figure 69. Central and South America AAV-based Gene Therapy Products Sales Volume (Units) by Type (2021-2031)
Figure 70. Central and South America AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Type (2020-2031)
Figure 71. Central and South America AAV-based Gene Therapy Products Sales Volume (Units) by Application (2020-2031)
Figure 72. Central and South America AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 73. Brazil AAV-based Gene Therapy Products Revenue (2020-2025) & (US$ Million)
Figure 74. Argentina AAV-based Gene Therapy Products Revenue (2020-2025) & (US$ Million)
Figure 75. Middle East, and Africa AAV-based Gene Therapy Products Sales YoY (2020-2031) & (Units)
Figure 76. Middle East and Africa AAV-based Gene Therapy Products Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Middle East and Africa Top 5 Manufacturers AAV-based Gene Therapy Products Sales Revenue (US$ Million) in 2024
Figure 78. Middle East and Africa AAV-based Gene Therapy Products Sales Volume (Units) by Type (2021-2031)
Figure 79. South America AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Middle East and Africa AAV-based Gene Therapy Products Sales Volume (Units) by Application (2020-2031)
Figure 81. Middle East and Africa AAV-based Gene Therapy Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. GCC Countries AAV-based Gene Therapy Products Revenue (2020-2025) & (US$ Million)
Figure 83. Turkey AAV-based Gene Therapy Products Revenue (2020-2025) & (US$ Million)
Figure 84. Egypt AAV-based Gene Therapy Products Revenue (2020-2025) & (US$ Million)
Figure 85. South Africa AAV-based Gene Therapy Products Revenue (2020-2025) & (US$ Million)
Figure 86. AAV-based Gene Therapy Products Industry Chain Mapping
Figure 87. Regional AAV-based Gene Therapy Products Manufacturing Base Distribution (%)
Figure 88. Global AAV-based Gene Therapy Products Production Market Share by Region (2020-2031)
Figure 89. AAV-based Gene Therapy Products Production Process
Figure 90. Regional AAV-based Gene Therapy Products Production Cost Structure
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
